the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

Summary

1. Gefitinib CTTQ production gefitinib and erlotinib sheet AstraZeneca imatinib sheet (trade name: Iressa ®) comparison, human pharmacokinetics and relative bioavailability of comparative studies which examine people in vivo pharmacokinetic behavior, provide the basis for clinical use. 2. Evaluation CTTQ gefitinib imatinib sheet production efficacy and safety of Chinese patients with locally advanced or metastatic non-small cell lung cancer.

Timeline

Start

2017-08

Primary completion

2021-12

Completion

2022-06

Drugs

Indications